JAMA, Your Integrity Is At Stake
"JAMA, your integrity is at stake." Chicago Tribune
All Bias, All BULL–Psychiatry Deception Re: ADHD Drugs Benefits_WashPost
ADHD published reports have been carefully crafted to declare pro-drug "conclusions"–but those conclusions are belied by the actual evidence about the long-term effects of ADHD drugs on children’s health.
AHRP Hits JAMA, Seeks Inquiry_WSJ
"The Alliance for Human Research Protection, which is often critical of industry-academic ties, made the requests in a letter it sent Wednesday to the AMA and the journal, also known as JAMA."
AMA-JAMA to Investigate Following AHRP Complaint
FOR IMMEDIATE RELEASE March 27, 2009 AMA REQUESTS JOURNAL OVERSIGHT COMMITTEE REVIEW Statement attributable to: Joseph M. Heyman, M.D. AMA Board Chair "The American Medical Association is owner and publisher of the Journal of the American Medical Association (JAMA) and its specialty Archives journals. While we are…
AHRP Letter of Complaint to AMA-JAMA
AHRP has sent a letter of complaint to the American Medical Association and the JAMA Oversight Committee calling for a public apology to Dr. Jonathan Leo by the AMA, a thorough investigation, the immediate suspension of the two editors involved, and a commitment to reviewing, clarifying and publishing JAMA’s editorial policies to protect against future violations of standards for professional conduct
JAMA Editor Should Apologize & Resign
JAMA Editor Ignites Firestorm By Calling Critic a ‘Nobody and a Nothing’_WSJ
Excess Deaths in VA Tretinoin-Retin-A Trial_FDA Silent
Even a seemingly harmless topical ointment may pose unanticipated lethal risks which are undisclosed on the FDA-approved label.
Letter of Complaint Re: FDA Double Agent
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels.
Letter of Complaint to FDA Commissioner, 2007
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.
The Damaging Impact of PDUFA and Why It Should be Repealed
The re-prioritization of rapid approvals occurred at the expense of drug safety standards,
Nicotine Fix–Evidence of Collusion: Pharma-Govt Smoking Guidelines
"The federal government's campaign could discourage potential quitters who don't want to spend money on quitting aids or don't like the idea of treating their nicotine addiction with more nicotine."
Evidence: Why you should never trust new wonder drugs
Pharmaceutical companies, much like the tobacco industry, have made fortunes by engaging in lies, deception, and illegal practices that are making people sick and causing premature deaths.